REFINED CHROMOSOME ANALYSIS AS AN INDEPENDENT PROGNOSTIC INDICATOR IN DENOVO MYELODYSPLASTIC SYNDROMES
Authors:
- JJ YUNISJYJJ YUNIS
- RE RYDELLRRRE RYDELL
- MM OKENMOMM OKEN
- MA ARNESENMAMA ARNESEN
- MG MAYERMMMG MAYER
- M LOBELLMLM LOBELL
- 1 June 1986
- journal article
- research article
- Vol. 67 (6) , 1721-1730
Abstract
In a study of 56 consecutive adult patients with de novo myelodysplastic syndromes (MDS), all cases were successfully analyzed with two refined chromosome banding techniques. Most patients (44 of 56, 79%) were found to have a chromosome defect. The majority of these patients had a recurrent loss of chromosomal material rather than a reciprocal translocation or inversion, as commonly found in acute leukemia. The three largest chromosomal categories found were associated with a wide range of survival. Twelve patients (21%) had normal chromosomes, a stable clinical course, and long survival (median follow-up time of 49 months, with all patients alive). Nine patients had in common a single chromosome defect resulting in either monosomy 7 or deletion 7q. They had a median survival of 12 months, and four died of acute nonlymphocytic leukemia (ANLL). Of 12 patients with complex defects, 11 had a complete or partial loss of a chromosome 5 and a complete or partial loss of the long arm of a chromosome 7 or 20. They had a poor median survival of four months, and six patients died of ANLL. Although the French-American-British (FAB) classification were also found to have some prognostic value, FAB subgroups were chromosomally heterogeneous and showed less dramatic differences in median survival than the larger chromosomal subgroups. We have shown, for the first time, that a refined chromosomal analysis is an independent prognostic indicator in de novo MDS and may be helpful in estalishing therapeutic approaches in this difficult group of heterogeneous disorders.Keywords
This publication has 14 references indexed in Scilit:
- Myelodysplastic syndromes. A clinical and pathologic analysis of 109 casesCancer, 1985
- Low-dose cytosine arabinoside (Ara-C) therapy in the myelodysplastic syndromes and acute leukemiaCancer, 1985
- Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 casesBlood, 1985
- Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysisBritish Journal of Haematology, 1985
- High-Resolution Chromosomes as an Independent Prognostic Indicator in Adult Acute Nonlymphocytic LeukemiaNew England Journal of Medicine, 1984
- Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemiaBritish Journal of Haematology, 1983
- Haematological features of primary myelodysplastic syndromes (PMDS) at initial presentation: a study of 118 cases.Journal of Clinical Pathology, 1983
- PHASE-I CLINICAL-TRIAL OF 13-CIS-RETINOIC ACID IN MYELODYSPLASTIC SYNDROMES1983
- Pathogenetic significance of ?pure? monosomy 7 in myeloproliferative disorders. analysis of 14 casesHuman Genetics, 1982
- NON-RANDOM CHROMOSOME-ABNORMALITIES IN ACUTE-LEUKEMIA AND DYSMYELOPOIETIC SYNDROMES IN PATIENTS WITH PREVIOUSLY TREATED MALIGNANT DISEASE1981